Orogen Royalties Inc.
Orogen Royalties Inc. (OGNRF) Financial Performance & Income Statement Overview
Review Orogen Royalties Inc. (OGNRF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Orogen Royalties Inc. (OGNRF) Income Statement & Financial Overview
Analyze Orogen Royalties Inc.’s OGNRF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.60M | $4.03M | $1.43M | $1.98M |
| Cost of Revenue | $18974.00 | $20421.00 | $20115.00 | $20270.00 |
| Gross Profit | $2.58M | $4.005M | $1.41M | $1.96M |
| Gross Profit Ratio | $0.99 | $0.99 | $0.99 | $0.99 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.51M | $884961.00 | $840923.00 | $938361.00 |
| Operating Expenses | $1.43M | $1.004M | $895650.00 | $2.70M |
| Total Costs & Expenses | $1.44M | $1.02M | $915765.00 | $2.72M |
| Interest Income | $261359.00 | $212667.00 | $138492.00 | $115512.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $18974.00 | $20421.00 | $20115.00 | $20270.00 |
| EBITDA | $1.04M | $2.67M | $522931.00 | $977060.00 |
| EBITDA Ratio | $0.40 | $0.66 | $0.37 | $0.49 |
| Operating Income | $1.16M | $3.001M | $512024.00 | $1.23M |
| Operating Income Ratio | $0.45 | $0.75 | $0.36 | $0.62 |
| Other Income/Expenses (Net) | $618592.00 | -$352363.00 | -$257520.00 | -$164810.00 |
| Income Before Tax | $1.78M | $2.65M | $254504.00 | $1.07M |
| Income Before Tax Ratio | $0.68 | $0.66 | $0.18 | $0.54 |
| Income Tax Expense | $599695.00 | $94672.00 | $614048.00 | $558217.00 |
| Net Income | $1.18M | $2.55M | -$359544.00 | $511256.00 |
| Net Income Ratio | $0.45 | $0.63 | -$0.25 | $0.26 |
| EPS | $0.006 | $0.01 | -$0.002 | $0.003 |
| Diluted EPS | $0.005 | $0.01 | -$0.002 | $0.002 |
| Weighted Avg Shares Outstanding | $201.70M | $201.65M | $201.54M | $199.05M |
| Weighted Avg Shares Outstanding (Diluted) | $212.93M | $209.03M | $201.54M | $209.52M |
Financial performance has remained strong, with revenue growing from $1.98M in Q2 2024 to $2.60M in Q1 2025. Gross profit continued to perform well, with margins at 99% in the latest quarter. Operating income reached $1.16M in Q1 2025, holding a steady 45% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.04M. Net income dropped to $1.18M, keeping EPS at $0.006. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan